SEC – ‘UPLOAD’ from 6/27/22 re: Koninklijke Philips NV – ‘TEXT-EXTRACT’

On:  Monday, 6/27/22, at 3:30pm ET   ·   Delayed-Release:  Filing ¶  –  Release Delayed   ·   Accession #:  0-22-6876

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Comment or Other Letter from the SEC   —   Delayed-Release

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: LETTER      Comment or Other Letter from the SEC                 PDF     37K 
 2: TEXT-EXTRACT  Comment or Other Letter from the SEC - PDF's         1      4K 
                Text                                                             

‘TEXT-EXTRACT’   —   Comment or Other Letter from the SEC – PDF’s Text

United States securities and exchange commission logo                           

June 27, 2022                       

Abhijit Bhattacharya                                              
Executive Vice President and Chief Financial Officer              
Koninklijke Philips NV                                            
Philips Center                                                    
Amstelplein 2, 1096 BC                                            
Amsterdam, The Netherlands                                        

                                                       Re: Koninklijke Philips
NV                                                                              
                                                         Form 20-F for the
Fiscal Year ended December 31, 2021                                             
                                                          Filed February 22,
2022                                                                            
                                                File No.
001-05146-01                                                                    

Dear Mr. Bhattacharya:                                            

           We have completed our review of your filing. We remind you that
the company and its                                                             
management are responsible for the accuracy and adequacy of their 
disclosures, notwithstanding                                                    
any review, comments, action or absence of action by the staff.   

Sincerely,                          

Division of Corporation Finance     

Office of Life Sciences             

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘UPLOAD’ Filing		Date		Other Filings
Filed on:		6/27/22		UPLOAD
		2/22/22		20-F,  6-K,  UPLOAD
		12/31/21		20-F,  SD,  UPLOAD
				List all Filings